Merck and Sanofi-Aventis abandoned plans to combine their animal-health businesses after wrestling with competition regulators for a year over potential divestitures.
The companies will now keep the Intervet and Merial units separate at no penalty to either side, they said in a statement today.
So what's really going on? My sources say that they think this deal came apart when Pfizer announced it was interested in divesting itself from Animal Health. With a "new potential spouse" in the room to be acquired (or parted out), both bride and groom suddenly decided they might hold off and see if they got a better offer (or a better deal) down the road.
.
No comments:
Post a Comment
All comments are moderated, and all zombies, trolls, time wasters, and anonymous cowards will be shot.
If you do not know what that means, click here and read the whole thing.
If you are commenting on a post, be sure to actually read the post.
New information, corrections, and well-researched arguments are always appreciated.
- The Management